| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/17/2011 | US20110064712 Dietary Supplement Compositions and Methods of Making and Using the Same |
| 03/17/2011 | CA2773615A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
| 03/17/2011 | CA2773594A1 Isoxazolidine derivatives |
| 03/16/2011 | EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295406A1 Heterocyclic compound |
| 03/16/2011 | EP2295066A1 Peptides, derivatives and analogs thereof, and methods of using same |
| 03/16/2011 | EP2294077A1 Corticosteroid linked beta-agonist compounds for use in therapy |
| 03/16/2011 | EP1879866B1 Dihydropyridine derivatives |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906139 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2451718C Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/10/2011 | WO2011029088A2 Preparation of raloxifene and its salts |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011027119A1 Combination medicament |
| 03/10/2011 | US20110060007 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059891 Alpha-msh therapies for treatment of autoimmune disease |
| 03/10/2011 | US20110059888 Metastin derivatives and use thereof |
| 03/10/2011 | CA2809198A1 Combination medicament |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292592A1 Sulfonamide compound and application thereof |
| 03/09/2011 | EP2292301A2 Anti-interferon-alpha antibodies |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292268A1 Pharmaceutical composition for use in treatment of diabetes |
| 03/09/2011 | EP2292239A2 Remedies for diseases to be applied to eye |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/08/2011 | US7902399 Fatty acids analogous |
| 03/08/2011 | CA2487532C Pyrrolidine derivatives as oxytocin antagonists |
| 03/08/2011 | CA2465667C New peptides - analogs of human growth hormone-releasing hormone |
| 03/03/2011 | WO2011023769A1 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
| 03/03/2011 | WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | WO2010147947A3 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
| 03/03/2011 | US20110054410 Liquid formulation of fsh |
| 03/03/2011 | US20110054021 Calcilytic Compounds |
| 03/03/2011 | US20110054011 RNA Antagonist Compounds for the Modulation of FABP4/AP2 |
| 03/03/2011 | US20110054005 Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same |
| 03/03/2011 | US20110053978 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053846 The use of gnrh antagonist peptide in the treatement of sex hormone-dependent diseases |
| 03/03/2011 | US20110052718 Synergistic Phytoceutical Compositions |
| 03/03/2011 | US20110052715 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 03/03/2011 | US20110052706 Pancreatine pellets and method of producing same |
| 03/03/2011 | US20110052699 Drug delivery system with stabilising effect |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052567 Methods Compositions, Uses, and Kits Useful for Vitamin D Deficiency and Related Disorders |
| 03/03/2011 | US20110052563 Gonadal function improving agents |
| 03/03/2011 | CA2772164A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/02/2011 | EP2289556A2 Pharmaceutical composition for use in treatment of diabetes |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289488A2 Remedies for diseases to be applied to eye |
| 03/02/2011 | EP2289487A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 03/02/2011 | EP2289486A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 03/02/2011 | EP2288369A1 Compositions of gnrh related compounds and processes of preparation |
| 03/02/2011 | EP1100824B1 Compounds with growth hormone releasing properties |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897603 Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 03/01/2011 | US7897560 Plasma protein affinity tags |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/24/2011 | WO2011022596A2 Preparation of bazedoxifene and its salts |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2009149139A8 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/24/2011 | US20110046110 Quinolines and related analogs as sirtuin modulators |
| 02/24/2011 | US20110046099 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110046095 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110045076 Linear order release polymer |
| 02/24/2011 | US20110045066 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110044939 Regulatory t cells in adipose tissue |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287184A2 Novel insulin derivatives |
| 02/23/2011 | EP2286818A1 Fulvestrant formulation |
| 02/23/2011 | EP2285394A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
| 02/23/2011 | EP2285383A2 Sequential administration of 20,20,21,21-pentafluoro-17-hydroxy-11 -ý4-(hydroxyacetyl) phenyl¨-19-nor-17 -pregna-4,9-diene-3-one and one or more progestational hormones for treating gynaecological diseases |
| 02/23/2011 | CN101981201A Oil producing microbes and methods of modification thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | CA2609667C Human proislet peptide, derivatives and analogs thereof, and methods of using same |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | US20110039929 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 02/17/2011 | US20110039883 Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors |
| 02/17/2011 | US20110039839 Cyanopyrroles |
| 02/17/2011 | US20110039814 Lipid composition |
| 02/17/2011 | US20110039775 Thyroid stimulating hormone fusion proteins |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284149A1 Selective androgen receptor modulators and methods of use thereof |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283867A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |